183 related articles for article (PubMed ID: 32578983)
1. Copper Complexes with 1,10-Phenanthroline Derivatives: Underlying Factors Affecting Their Cytotoxicity.
Nunes P; Correia I; Marques F; Matos AP; Dos Santos MMC; Azevedo CG; Capelo JL; Santos HM; Gama S; Pinheiro T; Cavaco I; Pessoa JC
Inorg Chem; 2020 Jul; 59(13):9116-9134. PubMed ID: 32578983
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of vanadium complexes with 1,10-phenanthroline ligands, quo vadis? Fate of complexes in cell media and cancer cells.
Nunes P; Correia I; Cavaco I; Marques F; Pinheiro T; Avecilla F; Pessoa JC
J Inorg Biochem; 2021 Apr; 217():111350. PubMed ID: 33477088
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
[TBL] [Abstract][Full Text] [Related]
4. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
[TBL] [Abstract][Full Text] [Related]
5. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
[TBL] [Abstract][Full Text] [Related]
6. DNA interaction of [Cu(dmp)(phen-dion)] (dmp=4,7 and 2,9 dimethyl phenanthroline, phen-dion=1,10-phenanthroline-5,6-dion) complexes and DNA-based electrochemical biosensor using chitosan-carbon nanotubes composite film.
Kashanian S; Khodaei MM; Roshanfekr H; Peyman H
Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():642-9. PubMed ID: 23811151
[TBL] [Abstract][Full Text] [Related]
7. Ni(ii)/Cu(ii)/Zn(ii) 5,5-diethylbarbiturate complexes with 1,10-phenanthroline and 2,2'-dipyridylamine: synthesis, structures, DNA/BSA binding, nuclease activity, molecular docking, cellular uptake, cytotoxicity and the mode of cell death.
Yilmaz VT; Icsel C; Suyunova F; Aygun M; Aztopal N; Ulukaya E
Dalton Trans; 2016 Jun; 45(25):10466-79. PubMed ID: 27263797
[TBL] [Abstract][Full Text] [Related]
8. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
9. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Spectral Characterization, DNA/ Protein Binding, DNA Cleavage, Cytotoxicity, Antioxidative and Molecular Docking Studies of Cu(II)Complexes Containing Schiff Base-bpy/Phen Ligands.
Anupama B; Aruna A; Manga V; Sivan S; Sagar MV; Chandrashekar R
J Fluoresc; 2017 May; 27(3):953-965. PubMed ID: 28097460
[TBL] [Abstract][Full Text] [Related]
11. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
12. Protein binding studies with human serum albumin, molecular docking and in vitro cytotoxicity studies using HeLa cervical carcinoma cells of Cu(ii)/Zn(ii) complexes containing a carbohydrazone ligand.
Parsekar SU; Velankanni P; Sridhar S; Haldar P; Mate NA; Banerjee A; Sudhadevi Antharjanam PK; Koley AP; Kumar M
Dalton Trans; 2020 Mar; 49(9):2947-2965. PubMed ID: 32073070
[TBL] [Abstract][Full Text] [Related]
13. Biological activity and photocatalytic properties of a naphthyl-imidazo phenanthroline (HNAIP) ligand and its [Ir(ppy)
Rubio AR; Fidalgo J; Martin-Vargas J; Pérez-Arnaiz C; Alonso-Torre SR; Biver T; Espino G; Busto N; García B
J Inorg Biochem; 2020 Feb; 203():110885. PubMed ID: 31731049
[TBL] [Abstract][Full Text] [Related]
14. In vitro DNA and BSA-binding, cell imaging and anticancer activity against human carcinoma cell lines of mixed ligand copper(II) complexes.
Anjomshoa M; Torkzadeh-Mahani M
Spectrochim Acta A Mol Biomol Spectrosc; 2015; 150():390-402. PubMed ID: 26057093
[TBL] [Abstract][Full Text] [Related]
15. Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.
Pivetta T; Isaia F; Verani G; Cannas C; Serra L; Castellano C; Demartin F; Pilla F; Manca M; Pani A
J Inorg Biochem; 2012 Sep; 114():28-37. PubMed ID: 22687563
[TBL] [Abstract][Full Text] [Related]
16. Fluorescent mixed ligand copper(II) complexes of anthracene-appended Schiff bases: studies on DNA binding, nuclease activity and cytotoxicity.
Jaividhya P; Ganeshpandian M; Dhivya R; Akbarsha MA; Palaniandavar M
Dalton Trans; 2015 Jul; 44(26):11997-2010. PubMed ID: 26076117
[TBL] [Abstract][Full Text] [Related]
17. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
[TBL] [Abstract][Full Text] [Related]
18. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structure information, DNA/BSA binding affinity and in vitro cytotoxic studies of mixed ligand copper(II) complexes containing a phenylalanine derivative and diimine co-ligands.
Annaraj B; Balakrishnan C; Neelakantan MA
J Photochem Photobiol B; 2016 Jul; 160():278-91. PubMed ID: 27155593
[TBL] [Abstract][Full Text] [Related]
20. New binary copper(II) complexes containing intercalating ligands: DNA interactions, an unusual static quenching mechanism of BSA and cytotoxic activities.
İnci D; Aydın R; Vatan Ö; Zorlu Y; Çinkılıç N
J Biomol Struct Dyn; 2018 Nov; 36(15):3878-3901. PubMed ID: 29132253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
